Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Age related changes in pancreatic beta cells: A putative extra-cerebral site of Alzheimer's pathology.

Maj M, Ilhan A, Neziri D, Gartner W, Berggard T, Attems J, Base W, Wagner L.

World J Diabetes. 2011 Apr 15;2(4):49-53. doi: 10.4239/wjd.v2.i4.49.

2.

Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.

Salminen A, Kaarniranta K, Kauppinen A, Ojala J, Haapasalo A, Soininen H, Hiltunen M.

Prog Neurobiol. 2013 Jul-Aug;106-107:33-54. doi: 10.1016/j.pneurobio.2013.06.002. Epub 2013 Jul 1. Review.

PMID:
23827971
3.

Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.

Asih PR, Tegg ML, Sohrabi H, Carruthers M, Gandy SE, Saad F, Verdile G, Ittner LM, Martins RN.

J Alzheimers Dis. 2017;59(2):445-466. doi: 10.3233/JAD-161259.

PMID:
28655134
4.

Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes.

Subauste A, Gianani R, Chang AM, Plunkett C, Pietropaolo SL, Zhang YJ, Barinas-Mitchell E, Kuller LH, Galecki A, Halter JB, Pietropaolo M.

PLoS One. 2014 Sep 16;9(9):e106537. doi: 10.1371/journal.pone.0106537. eCollection 2014.

5.

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.

Chen Z, Zhong C.

Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11. Review.

6.

Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62.

Jung HJ, Kim YJ, Eggert S, Chung KC, Choi KS, Park SA.

Exp Neurol. 2013 Oct;248:441-50. doi: 10.1016/j.expneurol.2013.07.013. Epub 2013 Jul 29.

PMID:
23906983
7.

A common pathogenic mechanism linking type-2 diabetes and Alzheimer's disease: evidence from animal models.

Park SA.

J Clin Neurol. 2011 Mar;7(1):10-8. doi: 10.3988/jcn.2011.7.1.10. Epub 2011 Mar 31.

8.

Genome-wide association studies: is there a genotype for cognitive decline in older persons with type 2 diabetes?

Abbatecola AM, Olivieri F, Corsonello A, Antonicelli R, Corica F, Lattanzio F.

Curr Pharm Des. 2011;17(4):347-56. Review.

PMID:
21352095
9.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
10.
11.

Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.

Kocherhans S, Madhusudan A, Doehner J, Breu KS, Nitsch RM, Fritschy JM, Knuesel I.

J Neurosci. 2010 Jul 7;30(27):9228-40. doi: 10.1523/JNEUROSCI.0418-10.2010.

12.

The pancreas-brain axis: insight into disrupted mechanisms associating type 2 diabetes and Alzheimer's disease.

Desai GS, Zheng C, Geetha T, Mathews ST, White BD, Huggins KW, Zizza CA, Broderick TL, Babu JR.

J Alzheimers Dis. 2014;42(2):347-56. doi: 10.3233/JAD-140018. Review.

PMID:
24858405
14.

Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.

Bitel CL, Kasinathan C, Kaswala RH, Klein WL, Frederikse PH.

J Alzheimers Dis. 2012;32(2):291-305. doi: 10.3233/JAD-2012-120571.

PMID:
22785400
15.

Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.

de la Monte SM.

Drugs. 2012 Jan 1;72(1):49-66. doi: 10.2165/11597760-000000000-00000. Review.

16.

Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.

Isopi E, Granzotto A, Corona C, Bomba M, Ciavardelli D, Curcio M, Canzoniero LM, Navarra R, Lattanzio R, Piantelli M, Sensi SL.

Neurobiol Dis. 2015 Sep;81:214-24. doi: 10.1016/j.nbd.2014.11.013. Epub 2014 Nov 28.

PMID:
25434488
17.

Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.

Caccamo A, Branca C, Talboom JS, Shaw DM, Turner D, Ma L, Messina A, Huang Z, Wu J, Oddo S.

J Neurosci. 2015 Oct 14;35(41):14042-56. doi: 10.1523/JNEUROSCI.2781-15.2015.

19.

Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease.

Wilcock DM, Gharkholonarehe N, Van Nostrand WE, Davis J, Vitek MP, Colton CA.

J Neurosci. 2009 Jun 24;29(25):7957-65. doi: 10.1523/JNEUROSCI.1339-09.2009. Erratum in: J Neurosci. 2010 Jan 20;30(3):1197-8.

20.

Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.

Martiskainen H, Viswanathan J, Nykänen NP, Kurki M, Helisalmi S, Natunen T, Sarajärvi T, Kurkinen KM, Pursiheimo JP, Rauramaa T, Alafuzoff I, Jääskeläinen JE, Leinonen V, Soininen H, Haapasalo A, Huttunen HJ, Hiltunen M.

Neurobiol Aging. 2015 Feb;36(2):1221.e15-28. doi: 10.1016/j.neurobiolaging.2014.09.003. Epub 2014 Sep 6.

PMID:
25281018

Supplemental Content

Support Center